SCHEMBL6492020

SCHEMBL6492020

CCCc1nn(C)c(C(N)=O)c1NC(=O)c1cc(S(=O)(=O)N2CC(C)NC(C)C2)ccc1OCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TERT O14746 5/20 0.53
PDE5A O76074 12/20 0.44
PDE3B Q13370 3/20 0.43
PDE3A Q14432 3/20 0.43
HDAC1 Q13547 4/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC2 Q92769 3/20 0.40
CA12 O43570 2/20 0.40
CA9 Q16790 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
PDE2A O00408 1/20 0.40
ABCC4 O15439 1/20 0.40
ABCC5 O15440 1/20 0.40
PDE6D O43924 1/20 0.40
PDE8A O60658 1/20 0.40
PDE9A O76083 1/20 0.40
ABCB11 O95342 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6492024 1.00 TERT (0.53) TERTPDE5APDE3BPDE3AHDAC1
SCHEMBL29897708 1.00 TERT (0.53) TERTPDE5APDE3BPDE3AHDAC1
SCHEMBL6730079 0.93 TERT (0.44) TERTPDE5APDE3BPDE3AHDAC1
SCHEMBL4565717 0.88 TERT (0.56) TERTPDE5APDE3BPDE3AHDAC1
SCHEMBL8125815 0.84 TERT (0.62) TERTPDE5APDE3BPDE3AKMT2A
SCHEMBL25925357 0.83 PDE5A (0.46) PDE5APDE3BPDE3AHDAC1HDAC6
SCHEMBL7006683 0.81 TERT (0.58) TERTPDE5AHDAC1HDAC6HDAC2
SCHEMBL7253729 0.81 TERT (0.58) TERTPDE5AHDAC1HDAC6HDAC2
SCHEMBL6207835 0.80 TERT (0.65) TERTPDE5APDE3BPDE3ACA12
SCHEMBL1705329 0.78 TERT (0.61) TERTPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1400522-B1 COMPOUNDS FOR TREATING IMPOTENCE GUANGZHOU YOUCARE BIOPHARMACEATICS CO LTD (CN) 2014-08-06 EP claimed
US-6960592-B2 1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one compound for the treatment of impotence LIU BAOSHUN 2005-11-01 US claimed
US-20040152709-A1 New compound for the treatment of impotence LIU BAOSHUN (CN) 2004-08-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152709-A1 New compound for the treatment of impotence PDE3B, PDE3A, PDE5A TERT 2811/4885PDE5A 3/4885PDE3B 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.